Western blot analysis showed that the combination of BNTX with TRAIL reduced XIAP expression and increased caspase-3 and PARP cleavage in tumor tissue extracts after 20 days of treatment (Figure 6B). This evidence concerns the gene CASP3 and neoplasm.